Position in NVS
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$247,304
-$387,725 QoQ
Shares Held
1,578
-65.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,220
of 1,603 holders
Holding Since
Dec 2023
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $358,862,750 across 12 Drug Manufacturers - General names. NVS ranks #12 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
239,779 | $86,828,771 | |
| 2 | ABBV |
AbbVie Inc.
|
268,264 | $67,505,952 | |
| 3 | MRK |
Merck & Co., Inc.
|
362,956 | $46,639,846 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
345,805 | $43,689,003 | |
| 5 | AZN |
Astrazeneca PLC
|
186,676 | $35,397,503 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
508,740 | $29,313,598 | |
| 7 | JNJ |
Johnson & Johnson
|
68,010 | $17,272,499 | |
| 8 | PFE |
Pfizer Inc
|
642,123 | $15,462,321 |
All Filings in NVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $247,304 | 1,578 | Shares | Defined | 2026-08-17 | |
| 2025-12-31 | $635,029 | 4,606 | Shares | Defined | 2026-02-09 | |
| 2023-12-31 | $4,991,653 | 49,437 | Shares | Defined | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||